CLEAR·OCEAN

DENTSPLY SIRONA Inc. (XRAY) — Insider Activity & Signal

Healthcare · Medical - Instruments & Supplies · Market cap $2.2B · $11.01 · 52-week range $9.41–$17.09

Recent insider buying

Open-market purchases reported to the SEC (last six months). Option grants and tax-withholding sales are excluded.

DateInsiderRoleSharesPriceValueSource
2026-06-15HOSEIN CLYDEdirector6,500$9.98$64,902SEC Form 4
2026-06-15Gladden Brian Tdirector9,985$10.02$100,000SEC Form 4
2026-06-12MAZELSKY JONATHAN JAYdirector10,000$10.14$101,400SEC Form 4
2026-06-12MCKEON BRIAN Pdirector10,000$10.12$101,200SEC Form 4
2026-06-11HOLDEN BETSY Ddirector10,086$9.88$99,692SEC Form 4
2026-06-11Barber Michael Jdirector15,175$9.88$150,005SEC Form 4
2026-03-09LUCIER GREGORY Tdirector15,000$12.45$186,675SEC Form 4
2026-03-09Forbes James Ddirector5,000$12.48$62,400SEC Form 4
2026-03-03LUCIER GREGORY Tdirector22,445$14.03$314,858SEC Form 4
2026-03-03Forbes James Ddirector5,000$13.47$67,345SEC Form 4
2026-03-02LUCIER GREGORY Tdirector27,555$14.24$392,521SEC Form 4

Financial health

Altman Z-Score 0.47 · Piotroski F-Score 4/9 · Cash $326M · Debt $2.5B

ClearOcean signal read

ClearOcean's model currently scores XRAY as a watchlist-level signal (5/10), based on the insider, fundamental and risk data above. This is a factual model output, not advice.

Sources & further reading

Last updated June 29, 2026.

ClearOcean is a software research tool, not an investment adviser or broker-dealer. This page aggregates public data (incl. SEC filings) for informational purposes only — it is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security. Past activity does not predict future results. You are solely responsible for your decisions; investing can lose value, up to total loss of capital.